PMC:7118659 / 9819-10037
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T19 | 133-145 | Body_part | denotes | cell surface | http://purl.org/sig/ont/fma/fma67653 |
T20 | 133-137 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T21 | 207-212 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T69 | 16-24 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T99 | 91-92 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T100 | 125-126 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T101 | 127-132 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T102 | 133-137 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T103 | 202-206 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
T104 | 202-206 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
T105 | 207-212 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T108 | 38-49 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T109 | 160-171 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 108-121 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
353 | 160-191 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
354 | 193-197 | Gene | denotes | ACE2 | Gene:59272 |
355 | 133-154 | Gene | denotes | cell surface receptor | Gene:57126 |
359 | 16-24 | Species | denotes | SARS-CoV | Tax:694009 |
369 | 38-49 | Chemical | denotes | chloroquine | MESH:D002738 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T56 | 0-218 | Sentence | denotes | The potent anti-SARS-CoV-1 effects of chloroquine in vitro were considered attributable to a deficit in the glycosylation of a virus cell surface receptor, the angiotensin-converting enzyme 2 (ACE2) on Vero cells [59]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32171740-16115318-48148554 | 214-216 | 16115318 | denotes | 59 |
T92796 | 214-216 | 16115318 | denotes | 59 |